Does apolipoprotein E genotype modify the clinical expression of ALS?

European Journal of Neurology

Volumn 18, Issue 4, 2011, Pages 618-624

  Jawaid, A ^a,c   Poon, M ^a   Strutt, A M ^a   Rice, L K ^a   Mcdowell, E J ^a   Salamone, A R ^a   Qureshi, S U ^a   Simpson, E ^b   Appel, S H ^b   York, M K ^a   Schulz, P E ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cohort study; Motor neuron disease; Neurological disorders; Neuromuscular diseases; Research methods

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAUCASIAN; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; TERTIARY HEALTH CARE;

AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; APOLIPOPROTEINS E; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMERASE CHAIN REACTION;

EID: 79952725883     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03225.x     Document Type: Article

References (39)

1. Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology 1996; 47: S71-S81.
2. Qureshi MM, Hayden D, Urbinelli L, et al. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler 2006; 7: 173-182.
3. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009; 10: 131-146.
4. Dupuis L, Corcia P, Fergani A, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008; 70: 1004-1009.
5. Jawaid A, Salamone AR, Strutt AM, et al. ALS disease onset may occur later in patients with diabetes mellitus. Eur J Neurol 2010; 17: 733-739.
6. Mahley RW, Rall SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507-537.
7. Lomnitski L, Koen R, Chen Y, et al. Reduced levels of antioxidants in brains of apolipoprotein E-deficient mice following closed head injury. Pharmacol Biochem Behav 1997; 56: 669-673.
8. Chen Y, Lomnitski L, Michaelson DM, Shohami E. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 1997; 80: 1255-1262.
9. Muller W, Meske V, Berlin K, Scharnagl H, Marz W, Ohm TG. Apolipoprotein E isoforms increase intracellular Ca2+ differentially through a omega-agatoxin IVa-sensitive Ca2+ -channel. Brain Pathol 1998; 8: 641-653.
10. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
11. Cosentino S, Scarmeas N, Helzner E, et al. ApoE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 2008; 70: 1842-1849.
12. Schiefermeier M, Kollegger H, Madl C, et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain 2000; 123: 585-590.
13. Parmenter BA, Denney DR, Lynch SG, Middleton LS, Harlan LM. Cognitive impairment in patients with multiple sclerosis: association with the ApoE gene and promoter polymorphisms. Mult Scler 2007; 13: 25-32.
14. Van Everbroeck B, Croes EA, Pals P, et al. Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob Disease phenotype. Neurosci Lett 2001; 313: 69-72.
15. Ariza M, Pueyo R, Matarín Mdel M, et al. Influence of ApoE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. J Neurol Neurosurg Psychiatry 2006; 77: 1191-1193.
16. Louko AM, Vilkki J, Niskakangas T. ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study. Acta Neurol Scand 2006; 114: 315-319.
17. Tian J, Shi J, Bailey K, Lendon CL, Pickering-Brown SM, Mann DM. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004; 75: 696-699.
18. Li YJ, Hauser MA, Scott WK, et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 2004; 62: 2005-2009.
19. Tsuang DW, Dalan AM, Eugenio CJ, et al. Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. Arch Neurol 2002; 59: 1622-1630.
20. Verpillat P, Camuzat A, Hannequin D, et al. Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. Eur J Hum Genet 2002; 10: 399-405.
21. Srinivasan R, Davidson Y, Gibbons L, et al. The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry 2006; 77: 154-158.
22. Borroni B, Perani D, Archetti S, et al. Functional correlates of Apolipoprotein E genotype in frontotemporal lobar degeneration. BMC Neurol 2006; 6: 31.
23. Moulard B, Sefiani A, Laamri A, Malafosse A, Camu W. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis. J Neurol Sci 1996; 139: 34-37.
24. Li YJ, Pericak-Vance MA, Haines JL, et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics 2004; 5: 209-213.
25. Drory VE, Birnbaum M, Korczyn AD, Chapman J. Association of ApoE epsilon4 allele with survival in amyotrophic lateral sclerosis. J Neurol Sci 2001; 190: 17-20.
26. Zetterberg H, Jacobsson J, Rosengren L, Blennow K, Andersen PM. Association of ApoE with age at onset of sporadic amyotrophic lateral sclerosis. J Neurol Sci 2008; 273: 67-69.
27. Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH Jr. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 460-463.
28. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994; 124: 96-107.
29. Appel V, Stewart S, Smith G, Appel S. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987; 22: 328-333.
30. Golden CJ. Identification of brain disorders by the Stroop Color and Word Test. J Clin Psychol 1976; 32: 654-658.
31. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999; 14: 167-177.
32. Gordon NG. The Trail Making Test in neuropsychological diagnosis. J Clin Psychol 1972; 28: 167-169.
33. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
34. Lacomblez L, Doppler V, Beucler I, et al. ApoE: a potential marker of disease progression in ALS. Neurology 2002; 58: 1112-1114.
35. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991; 49: 338-349.
36. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002; 155: 487-495.
37. Grober E, Sliwinski M. Development and validation of a model for estimating premorbid verbal intelligence in the elderly. J Clin Exp Neuropsychol 1991; 13: 933-949.
38. Bedlack RS, Strittmatter WJ, Morgenlander JC. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol 2000; 57: 1561-1565.
39. Batulan Z, Shinder GA, Minotti S, et al. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J Neurosci 2003; 23: 5789-5798.